CLARK IAN T
20 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | GH | Guardant Health, Inc. | Option exercise | 5,092 | $0.00 | $0.00 | filing |
| 2026-06-02 | BMRN | BIOMARIN PHARMACEUTICAL INC | Award | 7,490 | $0.00 | $0.00 | filing |
| 2026-05-27 | KYTX | Kyverna Therapeutics, Inc. | Award | 5,093 | $0.00 | $0.00 | filing |
| 2026-05-20 | GH | Guardant Health, Inc. | Sale | 6,876 | $106.90 | $735,048.53 | filing |
| 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Sale | 193,056 | $29.71 | $5.7M | filing |
| 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Sale | 41,840 | $30.48 | $1.3M | filing |
| 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Option exercise | 209,690 | $4.41 | $923,894.14 | filing |
| 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Sale | 29,904 | $28.83 | $862,132.32 | filing |
| 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Option exercise | 21,520 | $7.84 | $168,716.80 | filing |
| 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Option exercise | 21,520 | $3.61 | $77,687.20 | filing |
| 2025-12-19 | OLMA | Olema Pharmaceuticals, Inc. | Option exercise | 12,070 | $4.08 | $49,245.60 | filing |
| 2025-12-05 | GH | Guardant Health, Inc. | Sale | 17,055 | $107.27 | $1.8M | filing |
| 2025-12-05 | GH | Guardant Health, Inc. | Sale | 8,156 | $106.67 | $869,967.90 | filing |
| 2025-12-05 | GH | Guardant Health, Inc. | Sale | 3,400 | $108.05 | $367,354.36 | filing |
| 2025-12-05 | GH | Guardant Health, Inc. | Option exercise | 9,105 | $38.42 | $349,814.10 | filing |
| 2025-12-05 | GH | Guardant Health, Inc. | Option exercise | 10,703 | $31.84 | $340,783.52 | filing |
| 2025-12-05 | GH | Guardant Health, Inc. | Option exercise | 8,803 | $38.01 | $334,558.02 | filing |
| 2025-08-01 | BMRN | BIOMARIN PHARMACEUTICAL INC | Award | 7,000 | $0.00 | $0.00 | filing |
| 2025-07-08 | GDRX | GoodRx Holdings, Inc. | Option exercise | 17,248 | $4.74 | $81,755.52 | filing |
| 2025-06-17 | GH | Guardant Health, Inc. | Sale | 6,672 | $48.38 | $322,818.72 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.